Chinese Expert Consensus on Red Blood Cell Antigen Extended Matching Range

doi:10.3969/j.issn.1671-2587.2024.03.001

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2024, Vol. 26 ›› Issue (3): 289-298.DOI: 10.3969/j.issn.1671-2587.2024.03.001

Chinese Expert Consensus on Red Blood Cell Antigen Extended Matching Range

Expert consensus drafting group of red blood cell antigen extended matching range

Received:2024-05-19 Online:2024-06-20 Published:2024-06-24

Abstract

CLC Number:

R457

Expert consensus drafting group of red blood cell antigen extended matching range. Chinese Expert Consensus on Red Blood Cell Antigen Extended Matching Range[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 289-298.

References

[1] 国家卫生健康委员会.输血相容性检测标准[S].2022.
[2] 蓝燕飞,钟明璐,陈小洁,等.红细胞Rh血型相容性输血临床意义与经济性分析[J].临床输血与检验,2023,25(6):783-788.
[3] RADWANSKI K,GARRAUD O,COGNASSE F,et al.The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response[J].Transfusion,2013,53(12):3128-3138.
[4] HENDRICKSON J E,TORMEY C A.Understanding red blood cell alloimmunization triggers[J].Hematology Am Soc Hematol Educ Program,2016,2016(1):446-451.
[5] 林裕翔,许志远,蓝尹骏,等.北京地区人群红细胞抗体免疫病患发生新增抗体的累积发生率[J].中国输血杂志,2019,32(10):1021-1023.
[6] 李淑婷,张红星,王健.Rh表型匹配输注在自身抗体阳性患者输血中的应用价值[J].实用医技杂志,2022,29(7):723-727.
[7] CAMPBELL-LEE S A,GVOZDJAN K,CHOI K M,et al.Red blood cell alloimmunization in sickle cell disease:assessment of transfusion protocols during two time periods[J].Transfusion,2018,58(7):1588-1596.
[8] TORMEY C A,HENDRICKSON J E.Transfusion-related red blood cell alloantibodies:induction and consequences[J].Blood,2019,133(17):1821-1830.
[9] 王谦,燕备战,于洋.31766名患者红细胞血型不规则抗体分析[J].中国输血杂志,2011,24(11):966-968.
[10] 曹微微,舒象武,李碧娟,等.55481例住院拟输血患者红细胞血型不规则抗体分析[J].临床输血与检验,2013,15(3):238-240.
[11] YU Y,WANG Y,SUN X L,et al.Prevalence and specificity of red blood cell alloantibodies in patients from China during 1994-2013[J].Zhongguo Shi Yan Xue Ye Xue Za Zhi,2015,23(6):1734-1741.
[12] WANG Q S,YANG Q N,BAI Y Z,et al.Frequency of RBC alloantibodies in Chinese surgical patients[J].Transfus Med Hemother,2012,39(4):283-286.
[13] CHEN C X,TAN J Z,WANG L X,et al.Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review[J].Transfusion,2016,56(4):975-979.
[14] MO Z,LI H,HUANG L,et al.Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi[J].Transfus Med,2015,25(5):313-319.
[15] 洪毅,李菲,杨阳,等.56510例患者不规则抗体及特异性检测结果分析[J].海南医学,2021,32(2):222-224.
[16] 杨晓华,李玉秋,张慧娴,等.Rh和MNS血型系统临床输血患者不规则抗体的分布特点及意义[J].河北医药,2022,44(3):453-455.
[17] 许亚莉,吴继博,徐华,等.多中心联合筛查红细胞血型不规则抗体的大数据分析[J].中国输血杂志,2018,31(8):823-825.
[18] POLITOU M,VALSAMI S,DRYLLIS G,et al.Retrospective study on prevalence,specificity,sex,and age distribution of alloimmunization in two general hospitals in Athens[J].Turk J Haematol,2020,37(3):154-166.
[19] EVERS D,MIDDELBURG R A,HAAS M D,et al.Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity:a cohort study[J].Lancet Haematol,2016,3(6):e284-e292.
[20] WINTERS J L,PINEDA A A,GORDEN L D,et al.RBC alloantibody specificity and antigen potency in Olmsted County,Minnesota[J].Transfusion,2001,41(11):1413-1420.
[21] SPANOS T,KARAGEORGA M,LADIS V,et al.Red cell alloantibodies in patients with thalasseMi^a[J].Vox Sang,1990,58(1):50-55.
[22] 张保萍,张嵘,王文婷,等.谱细胞鉴定剂量效应分析偏差致抗-C抗体漏检1例[J].临床输血与检验,2021,23(2):236-239.
[23] 孙晓琳,于洋,关晓珍,等.“剂量效应” 现象对意外抗体鉴定的影响[J].中国实验血液学杂志,2015,23(1):222-227.
[24] 陈春霞,魏曾珍,谭金哲,等.国内抗体筛查细胞试剂比对[J].中国输血杂志,2017,30(11):1243-1245.
[25] 向东,范亮峰,刘曦,等.免疫性溶血性输血反应100例分析[J].临床输血与检验,2022,24(1):11-15.
[26] SCHONEWILLE H,VAN DE WATERING L M G,BRAND A.Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort:is it time to take precautionary measures?[J].Transfusion,2006,46(4):630-635.
[27] 崔颖,张勇萍,杨世明,等.不规则抗体筛选与特异性鉴定的影响因素及其对策分析[J].细胞与分子免疫学杂志,2022,38(2):165-170.
[28] TORMEY C A,STACK G.Immunogenicity of blood group antigens:a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies[J].Blood,2009,114(19):4279-4282.
[29] STACK G,TORMEY C A.Estimating the immunogenicit y of blood group antigens:a modified calculation that corrects for transfusion exposures[J].Br J Haematol,2016,175(1):154-160.
[30] AMEEN R,SHEMMARI S A,AL-BASHIR A.Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion[J].Transfusion,2009,49(8):1649-1654.
[31] FASANO R M,BOOTH G S,MILES M,et al.Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease[J].Br J Haematol,2015,168(2):291-300.
[32] CHOU S T,JACKSON T,VEGE S,et al.High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors[J].Blood,2013,122(6):1062-1071.
[33] CASTRO O,SANDLER S G,HOUSTON-YU P,et al.Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease:theoretical and practical implications[J].Transfusion,2002,42(6):684-690.
[34] ROMPHRUK A V,BUTRYOJANTHO C,JIRASAKONPA T B,et al.Phenotype frequencies of Rh (C,c,E,E),M,Mi^a and Kidd blood group systems among ethnic Thai blood donors from the north-east of Thailand[J].Int J Immunogenet,2019,46(3):160-165.
[35] 深圳市医师协会输血科医师分会.Rh血型相容性输血指南[S].深圳市医师协会. 2021
[36] 江西省输血协会.江西省Rh血型相容性输血专家共识[S].2022.
[37] 四川省医师协会输血科医师分会.Rh血型相容性输血指南(试行)[S].2023.
[38] 青岛市医学会输血医学专科分会.Rh血型相容性输血指南(试行)[S].2021.
[39] 广东省医院协会.Rh血型抗原检测应用标准[S].2023.
[40] TAHHAN H R,HOLBROOK C T,BRADDY L R,et al.Antigen-matched donor blood in the transfusion management of patients with sickle cell disease[J].Transfusion,1994,34(7):562-569.
[41] NOOR HASLINA M N,ARIFFIN N,ILLUNI HAYATI I,et al.Red cell immunization in multiply transfused Malay thalassemic patients[J].Southeast Asian J Trop Med Public Health,2006,37(5):1015-1020.
[42] ZAIDI U,BORHANY M,ANSARI S,et al.Red cell alloimmunisation in regularly transfused beta thalasseMi^a patients in Pakistan[J].Transfus Med,2015,25(2):106-110.
[43] 施艺璇,何苏英,彭永正.电子匹配信息系统辅助的Rh血型五抗原配合性输注的安全性和有效性研究[J].临床输血与检验,2023,25(3):379-383.
[44] ZHANG Y,LI X F.Is antigen-negative matching strategy in non-ABO blood system between donors and recipients a practical reality?[J].Transfus Clin Biol,2023,30(2):184-185.
[45] AMEEN R,AL-SHEMMARI S,AL-HUMOOD S,et al.RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalasseMi^a patients[J].Transfusion,2003,43(11):1604-1610.
[46] RIBEIRO K R,GUARNIERI M H,DA COSTA D C,et al.DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease[J].Vox Sang,2009,97(2):147-152.
[47] YANG Q X,LI A J,WANG C,et al.Fully genotyping and screening of clinically important blood-group antigens by MALDI TOF mass spectrometry[J].Electrophoresis,2024,45(5/6):548-556.
[48] FÜRST D,TSAMADOU C,NEUCHEL C,et al.Next-generation sequencing technologies in blood group typing[J].Transfus Med Hemother,2020,47(1):4-13.
[49] ROPHINA M,PANDHARE K,JADHAO S,et al.BGvar:a comprehensive resource for blood group immunogenetics[J].Transfus Med,2022,32(3):229-236.
[50] PATNAIK S K,BLUMENFELD O O.Patterns of human genetic variation inferred from comparative analysis of allelic mutations in blood group antigen genes[J].Hum Mutat,2011,32(3):263-271.
[51] WHEELER C A,CALHOUN L,BLACKALL D P.Warm reactive autoantibodies:clinical and serologic correlations[J].Am J Clin Pathol,2004,122(5):680-685.
[52] BLACKALL D P,WHEELER C A.Contemporaneous autoantibodies and alloantibodies[J].Transfusion,2007,47(7):1332.
[53] DELANEY M,APELSETH T O,BONET BUB C,et al.Red-blood-cell alloimmunization and prophylactic antigen matching for transfusion in patients with warm autoantibodies[J].Vox Sang,2020,115(6):515-524.
[54] ZIMAN A,COHN C,CAREY P M,et al.Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices:review of the literature and survey of current practice[J].Transfusion,2017,57(2):463-477.
[55] 王雨涵,王华,王洁,等.RhCcEe抗原配合性悬浮红细胞输注在温抗体型AIHA患者紧急输血中的应用[J].四川医学,2021,42(1):31-34.
[56] 邵超鹏,骆群,伍昌林.输血依赖型地中海贫血(TDT)患者临床输血中国专家共识[J].临床输血与检验,2023,25(2):163-169.
[57] 杨政道,赵鼎,田冬冬.β-地中海贫血患者长期红细胞输注中应用RhCcEe抗原配合性输血策略的应用效果评估[J].中国医学工程,2021,29(5):36-39.
[58] 王雨涵,王华,王洁,等.RhCcEe抗原配合性输血在β-地中海贫血患者血液输注中的应用[J].中国输血杂志,2019,32(4):349-351.
[59] ORTIZ S,ORERO M T,JAVIER K,et al.Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome[J].Trasfusione Del Sangue,2017,15(5):472-477.
[60] GUELSIN G A S,RODRIGUES C,VISENTAINER J E L,et al.Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome[J].Blood Transfus,2015,13(1):53-58.
[61] LIN Y,SASKIN A,WELLS R A,et al.Prophylactic RhCE and Kell antigen matching:impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes[J].Vox Sang,2017,112(1):79-86.
[62] 江灵,王华,王静,等.RhCcEe抗原配合性输血在多次输血患者中的应用[J].医学信息,2022,35(9):168-170.
[63] 王书亚,孔永奎,王莉,等.Rh分型同型输注对于反复输血患者的必要性分析[J].郑州大学学报(医学版),2021,56(4):555-559.
[64] OUD J A,EVERS D,HAAS M D,et al.The effect of extended c,E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation[J].Br J Haematol,2021,195(4):604-611.
[65] BODNAR M,LIEBERMAN L,ARSENAULT V,et al.The selection and preparation of red cell components for intrauterine transfusion:a national survey[J].Vox Sang,2024,119(3):265-271.
[66] DOYLE B,QUIGLEY J,LAMBERT M,et al.Red cell alloimmunisation following intrauterine transfusion and the feasibility of providing extended phenotype-matched red cell units[J].Transfus Med,2014,24(5):311-315.
[67] WONG K,LAI W K,JACKSON D E.HLA Class II regulation of immune response in sickle cell disease patients:susceptibility to red blood cell alloimmunization (systematic review and meta-analysis)[J].Vox Sang,2022,117(11):1251-1261.

Chinese Expert Consensus on Red Blood Cell Antigen Extended Matching Range

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	MENG Weicheng, CHEN Yaozhen, WANG Yafen, AN Ning, LIU Zhixin, WU Xiaoshuang, WANG Fei, HU Xingbin. The Impact of Reduced Bisphosphoglycerate Mutase（BPGM）Enzyme Activity in Sensitized Red Blood Cells on Oxygen Carrying/Releasing Capacity [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 308-314.
[2]	XIAO Pan, LIU Yulin, XUE Xiaonan, XUE Yingna, LIU Yi, SUN Liping, YU Yang. Proteomic Analysis of Plasma Exosomes from Young Versus Middle-aged People [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 315-325.
[3]	YANG Hao, DONG Shuling, YANG Qiankun, HAN Yue, WANG Shuya, JIN Huifang, ZHENG Lu, TANG Yue. Effect of Double Filtration Plasmapheresis and Plasma Exchange on Blood Type Antibody Removal in ABO-incompatible Kidney Transplantation Recipients: A Single Center Comparative Analysis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 325-331.
[4]	ZHAO Nan, LU Jiangtao, HE Ling, CHEN Xiaoling, ZHANG Wenjie, ZHANG Dafa, TANG Zongsheng. Comprehensive Effect of Autologous Plateletpheresis and Transfusion Technology in Patients with ATAAD [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 332-337.
[5]	CHEN Tingting, HUANG Rong, LING Yu, HU Wenjing. Analysis of Correlation and Influencing Factors between RhD Negative Pregnant Women and the Occurrence of HDFN [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 338-345.
[6]	FAN Chengyan, WEN Yujie, ZHANG Dan, LIAN Xue, LIU Na, SUN Tiecheng, WANG Dongmei, JIA Yanjun, LI Dongmei. Analysis of HLA/HPA Antibody Specificity and Its Impact on Platelet Transfusion Outcomes in Patients with Immune Platelet Transfusion Refractoriness [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 353-358.
[7]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 394-398.
[8]	HE Minwei, ZHOU Qianqian, ZHANG Ke, ZHAN Linsheng. Research Advances in Blood Transfusion Medicine in the Year of 2023 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 399-403.
[9]	ZHAO Ziyue, HUANG Weihua, CHA Zhanshan. The Prospect of Combined Application of Platelet-rich Plasma and Mesenchymal Stem Cells in Regenerative Medicine [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 420-426.
[10]	Chinese Blood Transfusion Association Clinical Transfusion Management Committee. Chinese Expert Consensus on Preoperative Advanced Autologous Apheresis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 145-155.
[11]	ZHANG Leiying, YU Yang. Risks of ABO Non-identical Plasma:Cognitive and Clinical Practice [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 164-172.
[12]	LIU Ruining, WANG Deqing. Current Realities and Novel Improvements of Plasma Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 180-186.
[13]	XIE Huihan, SHAO Xiaobao, CHEN Xin, ZHOU Lin, ZHU Peiyuan. Characterization of Salidroside for the Preservation of Apheresis Platelets [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 196-204.
[14]	FAN Rui, FENG Chunyu, WANG Yujing, SHANG Weiwei, TANG Wenfei, MA Haimei, ZHANG Huan. Exploration of Effect on the Quality of Red Blood Cells Suspended during Pressurized Transfusion in Vitro Simulation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 223-229.
[15]	TONG Xinxin, ZHONG Minglu, HUANG huiying, DENG Hui, HUANG Jianyun, WEI Yaming. Transformation of Rh Blood Group in Patients with Blood Diseases Treated with Allogeneic Hematopoietic Stem Cell Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 230-235.